The Incidence and Risk Analysis of Lung Cancer Development in Patients with Chronic Obstructive Pulmonary Disease: Possible Effectiveness of Annual CT-Screening

The Incidence and Risk Analysis of Lung Cancer Development in Patients with Chronic Obstructive Pulmonary Disease: Possible Effectiveness of Annual CT-Screening

Hiroyoshi Machida,1 Sumito Inoue,1 Yoko Shibata,2 Tomomi Kimura,3 Takahito Ota,1 Yu Ishibashi,1 Hiroaki Murano,1 Kodai Furuyama,1 Sujeong Yang,1 Hiroshi Nakano,1 Kento Sato,1 Masamichi Sato,1 Takako Nemoto,1 Michiko Nishiwaki,1 Keiko Yamauchi,1 Akira Igarashi,1 Masafumi Watanabe1 1Department of Card...

Full description

Bibliographic Details
Main Authors:	Machida H, Inoue S, Shibata Y, Kimura T, Ota T, Ishibashi Y, Murano H, Furuyama K, Yang S, Nakano H, Sato K, Sato M, Nemoto T, Nishiwaki M, Yamauchi K, Igarashi A, Watanabe M
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-03-01
Series:	International Journal of COPD
Subjects:	chronic obstructive pulmonary disease (copd) lung cancer gold classification current smoker inhaled corticosteroid (ics)
Online Access:	https://www.dovepress.com/the-incidence-and-risk-analysis-of-lung-cancer-development-in-patients-peer-reviewed-article-COPD

Similar Items

Methacholine challenge test as indicator for add on inhaled corticosteroids in COPD patients
by: M. Hantera, et al.
Published: (2014-04-01)

Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
by: Yamauchi Y, et al.
Published: (2016-06-01)

Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?
by: Faisal A AI-Kassimi, et al.
Published: (2013-01-01)

The dose of inhaled corticosteroids in patients with COPD: when less is better
by: Izquierdo JL, et al.
Published: (2018-10-01)

Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies
by: Lodise TP, et al.
Published: (2020-11-01)

Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience
by: Sun Hye Shin, et al.
Published: (2020-08-01)

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
by: Cheng SL, et al.
Published: (2016-09-01)

Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
by: Cheng SL
Published: (2018-09-01)

Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short
by: Tantucci C, et al.
Published: (2020-04-01)

Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan
by: Hirano R, et al.
Published: (2018-10-01)

Contributing Factors for Underutilization of Inhaled Corticosteroids Among Asthmatic Patients Attending at Adama Hospital Medical College, Adama, Ethiopia
by: Tadesse S, et al.
Published: (2020-09-01)

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
by: Lutter JI, et al.
Published: (2021-04-01)

Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies
by: Hollis S, et al.
Published: (2017-04-01)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
by: Janson C, et al.
Published: (2017-10-01)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
by: Yoon JK, et al.
Published: (2020-08-01)

Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review
by: Hannah R. Whittaker, et al.
Published: (2019-12-01)

GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap
by: Roman-Rodriguez M, et al.
Published: (2021-06-01)

Characterization of COPD Admissions During the First COVID-19 Outbreak
by: Cosio BG, et al.
Published: (2021-06-01)

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting
by: Whittaker HR, et al.
Published: (2019-05-01)

Quality of life assessment in asthmatic patients receiving fluticasone compared with equipotent doses of beclomethasone or budesonide
by: Thomas Sabin, et al.
Published: (2005-01-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study
by: Jones R, et al.
Published: (2017-08-01)

Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
by: Erminia Ridolo, et al.
Published: (2018-05-01)

Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature
by: Caramori G, et al.
Published: (2019-05-01)

Glucocorticoid-driven transcriptomes in human airway epithelial cells: commonalities, differences and functional insight from cell lines and primary cells
by: Mahmoud M. Mostafa, et al.
Published: (2019-01-01)

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
by: Helgo Magnussen, et al.
Published: (2021-01-01)

January 2015 Tucson pulmonary journal club: withdrawal of inhaled glucocorticoids in COPD
by: Wong C, et al.
Published: (2015-02-01)

Osteopontin in chronic obstructive pulmonary disease: Smokers and ex-smokers
by: Ahmed A Ali, et al.
Published: (2015-01-01)

A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management
by: Micheletto C, et al.
Published: (2019-09-01)

In vitro Evaluation of Dry Powder Inhaler Devices of Corticosteroid Preparations
by: Gen Tamura, et al.
Published: (2012-01-01)

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
by: Donald P. Tashkin, et al.
Published: (2018-10-01)

Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease
by: Ahmed Fahim, et al.
Published: (2012-01-01)

Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care
by: Savran O, et al.
Published: (2020-04-01)

Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease
by: Sicras Mainar A, et al.
Published: (2019-09-01)

Essential need for rethink of COPD airway pathology: implications for new drug approaches for prevention of lung cancer as well as small airway fibrosis
by: Sohal SS, et al.
Published: (2017-09-01)

Withdrawal of Inhaled Corticosteroids in Patients with COPD – A Prospective Observational Study
by: Nielsen AO, et al.
Published: (2021-03-01)

Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials
by: Hong Chen, et al.
Published: (2020-10-01)

PARC/CCL18 is Associated with Inflammation, Emphysema Severity and Application of Inhaled Corticosteroids in Hospitalized COPD Patients
by: Duan H, et al.
Published: (2021-05-01)

The Effects of Inhaled Airway Directed Pharmacotherapy on Decline in Lung Function Parameters Among Indigenous Australian Adults With and Without Underlying Airway Disease
by: Heraganahally SS, et al.
Published: (2021-09-01)

Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
by: Soltani A, et al.
Published: (2016-09-01)

Cannot write session to /tmp/vufind_sessions/sess_gaoeobtrr2h7ot689vdth45jjb